One of the most comprehensive statistical analyses of drivers of food insecurity across 65 countries has concluded that household income consistently explains more discrepancy in food security than any other factor, including agricultural land resources and production.
Results suggest vaccination against COVID-19 remains crucial even in young adults who were previously infected.
New research sheds light on how autism-spectrum disorder manifests in the brains of girls, prompting the scientists to warn that conclusions drawn from studies conducted primarily in boys should not be assumed to hold true for girls.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from NIH scientists. MK-4482, delivered orally, is now in human clinical trials. Remdesivir, an antiviral drug already approved by the U.S. Food and Drug Administration for use against COVID-19, must be provided intravenously, making its use primarily limited to clinical settings.
Researchers at the Medical University of South Carolina have developed a new digital platform called Research Integrated Network of Systems (RINS). This platform enables information about clinical studies to be more easily shared across disparate systems. RINS provides a much-needed means to track clinical studies and measure their success. The decentralized program allows users from different disciplines or administrative offices to utilize the system that works best for them while maintaining a comprehensive reporting mechanism.
A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing.
The study has demonstrated the involvement of a new Ca2+ ion entry pathway in angiogenesis processes and the formation of new blood vessels. This Ca2+ pathway is known as SOCE (store operated Ca2+ entry).
The preliminary trial results of a novel radiopharmaceutical for PET imaging of inflammation developed at the University of Turku, Finland, have been published. The compound, which targets the vascular adhesion protein 1 (VAP-1) that regulates inflammatory cell traffic, is the first radiopharmaceutical that has been developed completely in Finland and has advanced to clinical trials. In the study that started with healthy volunteers, the radiopharmaceutical was found to be well tolerated and safe.
If you are exposed to silica (quartz) dust at work - e.g. from working with concrete and granite - you have a greater risk of certain types of rheumatic disease. This is shown by results from Aarhus University and Aarhus University Hospital, which have just been published in the International Journal of Epidemiology.
A new study has shown that underweight and overweight women are at a significantly higher risk of experiencing recurrent miscarriages compared to those of average weight.